Akanda Corp. (AKAN)

USD 1.13

(0.71%)

Total Liabilities Summary of Akanda Corp.

  • Akanda Corp.'s latest annual total liabilities in 2023 was 12.66 Million USD , up 4.73% from previous year.
  • Akanda Corp.'s latest quarterly total liabilities in 2024 Q2 was 5.39 Million USD , down 0.0% from previous quarter.
  • Akanda Corp. reported annual total liabilities of 12.09 Million USD in 2022, up 18.05% from previous year.
  • Akanda Corp. reported annual total liabilities of 10.24 Million USD in 2021, up 10.11% from previous year.
  • Akanda Corp. reported quarterly total liabilities of 14.85 Million USD for 2023 Q2, down 0.0% from previous quarter.
  • Akanda Corp. reported quarterly total liabilities of 12.66 Million USD for 2023 FY, up 4.73% from previous quarter.

Annual Total Liabilities Chart of Akanda Corp. (2023 - 2019)

Historical Annual Total Liabilities of Akanda Corp. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 12.66 Million USD 4.73%
2022 12.09 Million USD 18.05%
2021 10.24 Million USD 10.11%
2020 9.3 Million USD 0.0%
2019 - USD 0.0%

Peer Total Liabilities Comparison of Akanda Corp.

Name Total Liabilities Total Liabilities Difference
Collegium Pharmaceutical, Inc. 947.87 Million USD 98.663%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -37.756%
Embecta Corp. 2.03 Billion USD 99.378%
Pacira BioSciences, Inc. 704.25 Million USD 98.201%
PainReform Ltd. 2.69 Million USD -370.787%
Sunshine Biopharma, Inc. 6.13 Million USD -106.347%
SCYNEXIS, Inc. 55.45 Million USD 77.153%
Journey Medical Corporation 56.49 Million USD 77.577%
Safety Shot Inc 3.89 Million USD -225.507%
Alpha Teknova, Inc. 38.55 Million USD 67.137%
Bright Green Corporation 6.43 Million USD -96.78%
Procaps Group, S.A. 462.06 Million USD 97.258%
Alvotech 1.88 Billion USD 99.327%
ANI Pharmaceuticals, Inc. 471.67 Million USD 97.314%
Aquestive Therapeutics, Inc. 163.9 Million USD 92.271%
Cosmos Health Inc. 30.25 Million USD 58.123%
Dynavax Technologies Corporation 375.02 Million USD 96.622%
Esperion Therapeutics, Inc. 660.79 Million USD 98.083%
Intra-Cellular Therapies, Inc. 136.87 Million USD 90.744%
Sunshine Biopharma, Inc. 6.13 Million USD -106.347%
Theratechnologies Inc. 98.63 Million USD 87.156%
Harrow Health, Inc. 241.75 Million USD 94.76%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -44.688%
Biofrontera Inc. 23.13 Million USD 45.249%
DURECT Corporation 30.4 Million USD 58.334%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 97.401%
Cronos Group Inc. 43.73 Million USD 71.033%
OptiNose, Inc. 194.33 Million USD 93.481%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 98.45%
Kala Pharmaceuticals, Inc. 48.44 Million USD 73.849%
RedHill Biopharma Ltd. 20.97 Million USD 39.609%
Organogenesis Holdings Inc. 181.36 Million USD 93.015%
Guardion Health Sciences, Inc. 3.77 Million USD -235.855%
Cumberland Pharmaceuticals Inc. 52.51 Million USD 75.876%
Radius Health, Inc. 804.29 Million USD 98.425%
Universe Pharmaceuticals INC 13.75 Million USD 7.892%
ProPhase Labs, Inc. 42.54 Million USD 70.222%
Phibro Animal Health Corporation 725.54 Million USD 98.254%
Procaps Group S.A. 462.06 Million USD 97.258%
TherapeuticsMD, Inc. 14.02 Million USD 9.65%
Viatris Inc. 27.21 Billion USD 99.953%
Rockwell Medical, Inc. 30.88 Million USD 58.976%
Aytu BioPharma, Inc. 90.37 Million USD 85.982%
SIGA Technologies, Inc. 57.97 Million USD 78.149%
Tilray Brands, Inc. 892.11 Million USD 98.58%
Lifecore Biomedical, Inc. 219.8 Million USD 94.236%
Shineco, Inc. 47.6 Million USD 73.386%
PetIQ, Inc. 645.22 Million USD 98.037%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -5671.386%
Incannex Healthcare Limited 5.83 Million USD -117.305%
Neurocrine Biosciences, Inc. 1.01 Billion USD 98.757%
Alimera Sciences, Inc. 107.35 Million USD 88.199%
Silver Spike Investment Corp. 3 Million USD -320.917%
Assertio Holdings, Inc. 148.41 Million USD 91.464%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -568.202%
Petros Pharmaceuticals, Inc. 21.31 Million USD 40.566%
Clever Leaves Holdings Inc. 7.02 Million USD -80.314%
Cyclo Therapeutics, Inc. 8.49 Million USD -49.212%
Avadel Pharmaceuticals plc 173.38 Million USD 92.693%
Hempacco Co., Inc. 18.82 Million USD 32.693%
Talphera, Inc. 6.29 Million USD -101.413%
Alvotech 1.88 Billion USD 99.327%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 92.66%
Lantheus Holdings, Inc. 835.25 Million USD 98.483%
Currenc Group, Inc. 177.67 Million USD 92.87%
Kamada Ltd. 109.96 Million USD 88.48%
Indivior PLC 1.95 Billion USD 99.351%
Evoke Pharma, Inc. 9.64 Million USD -31.31%
Flora Growth Corp. 17.22 Million USD 26.438%
Cyclo Therapeutics, Inc. 8.49 Million USD -49.212%
Evolus, Inc. 209.68 Million USD 93.958%
HUTCHMED (China) Limited 536.38 Million USD 97.638%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 98.55%